ARTICLE | Clinical News
Wyeth Lederle regulatory update
March 15, 1999 8:00 AM UTC
The FDA granted fast-track designation to Wyeth Lederle's seven-valent pneumococcal vaccine to prevent invasive pneumococcal disease in children. Wyeth Lederle is a business unit of Wyeth-Ayerst Labo...